Science news and discoveries from the Mass General Research Institute
Bench PressBench PressBench PressBench Press
  • Home
  • About
  • Research
    • COVID-19
    • Brain
    • Heart
    • Cancer
    • More…
  • Communicating Science
  • Events
  • Subscribe

Heart Health Month 2019: Spotlighting Mass General’s Heart Researchers (Part 1)

By gir0 | Cardiology, Events, Researcher Profiles | 1 comment | 5 February, 2019 | 0

Heart disease is the leading cause of death for both men and women in the United States. This includes conditions such as coronary artery disease, heart attack, stroke, heart failure and others according to the American Heart Association.

Mass General is home to a vast community of researchers studying the causes of heart disease and working to develop new prevention and treatment strategies.

Since every February is dedicated to heart health awareness, we reached out to some of our cardiology researchers to see what they’re working on.

Read on for the first post in our Heart Month 2019 series!

Matthias Nahrendorf, PhD

Principal investigator at Mass General’s Center for Systems Biology
Director of the Mouse Imaging Program
Weissman Family MGH Research Scholar 2014-2019

Dr. Nahrendorf, is pursuing a deeper understanding of the consequences of ischemic injury (damage caused by a lack of oxygenated blood coming in the heart, which can be result from narrowed arteries) and how the healing process after a cardiac event such as heart attack can contribute to heart failure down the line.

He is also developing molecular imaging tools to non-invasively study regulators of heart failure biology and infarct healing processes. Infarcts are areas of dead tissue that result when the supply of oxygenated blood is cut off from the heart.

It is thought that an excessive increase in immune cell activity that occurs in response to a heart attack may cause a chain reaction that results in the stiffing or scarring of tissues in the heart. These stiffened tissues limit the heart’s ability to contract and pump effectively, which in turn limits the amount of oxygenated blood it can process and can lead to heart failure.

A long-term goal is to devise new therapies to reduce the activity of these inflammatory cells to do only what is necessary to promote healthy healing. If that could be achieved, “Ideally we wouldn’t have heart failure anymore.”

Recent publications:

  • Macrophages Facilitate Electrical Conduction in the Heart

Malissa Wood, MD

Co-Director, Corrigan Women’s Heart Health Program

Dr. Wood’s clinical practice is primarily devoted to the diagnosis and treatment of heart disease in women. According to the National Heart, Lung and Blood Institute, 1 in 5 women die from heart disease in the United States and 9 out of 10 women have at least one risk factor for heart disease.

Dr. Wood currently serves as the Co-Director of the Massachusetts General Hospital Heart Center Corrigan Women’s Health Program and is the principal investigator of the Happy Heart Trial, a primary prevention in low income women study designed to improve the cardiovascular health of high risk women.

Here’s how Dr. Malissa Wood is working to help women with cardiovascular disease:

Recent publications:

  • Valvular Heart Disease and Heart Failure in Women
  • How do we attract and retain women in cardiology?
  • Heart Centers for Women

Anthony Rosenzweig, MD

Chief, Cardiology Division
Co-Director, Corrigan Minehan Heart Center

Dr. Rosenzweig is a widely published expert on mechanisms of heart failure and the benefits of exercise, and presents internationally on his research.

His research is focused on heart failure and understanding the clinical implications of fundamental biological processes regulating cell growth, death and regeneration in the heart.

Through his laboratory research, he has worked to identify and validate novel therapeutic targets to address heart failure, as well as studying what keeps the heart healthy, using the exercised heart as a model.

Recent publications:

  • Exercise induces new cardiomyocyte generation in the adult mammalian heart

Ami B. Bhatt, MD

Director, MGH Adult Congenital Heart Disease Program

Dr. Bhatt is an active clinical cardiologist, clinical investigator and educator.
Her interests focus on four main areas in adult congenital heart disease: vascular disease, risk prediction, transition and adult congenital heart disease education (ACHD).

She is dedicated to patient advocacy groups and empowering individuals with CHD to lead full and productive lives. She recently published a book that aims to help general cardiologists, pediatricians and related care providers with the management and diagnosis of adult CHD.

Check out the video below to learn about some of Dr. Bhatt’s research:

Recent publications:

  • Adult Congenital Heart Disease in Clinical Practice
  • Subclinical Burden of Coronary Artery Calcium in Patients With Coarctation of the Aorta

About the Mass General Research Institute
Massachusetts General Hospital is home to the largest hospital-based research program in the United States. Our researchers work side-by-side with physicians to develop innovative new ways to diagnose, treat and prevent disease.
Support our research

heart disease, heart failure, heart month, hypertension

Related Post

  • Heart Health Month 2019: Spotlighting Mass General’s Heart Researchers (Part 3)

    By gir0 | 0 comment

    Part 3 marks the last of our Heart Month researcher spotlight series, and we hope you’ve enjoyed learning about the work being in the name of heart health.

  • Heart Health Month 2019: Spotlighting Mass General’s Heart Researchers (Part 2)

    By gir0 | 1 comment

    Learn more about the latest research in cardiology from some of Mass General’s leading heart health specialists.

  • Cardiac Psychiatry: Exploring Connections Between the Head and the Heart

    By gir0 | 2 comments

    Cardiac psychiatry, also called behavioral cardiology, explores the connections between mental health, behavior and medical health.

  • Surveys Show How Symptoms and Their Impacts Differ Among Adults with a Congenital Heart Defect

    By mghresearch | 0 comment

    When it comes to treating the symptoms of patients with a congenital heart defect, researchers from Massachusetts General Hospital are finding that a one-size-fits-all approach won’t meet all patients’ needs. The results of their recent survey provide insight into how clinicians can best tailor care for these patients.

  • Mass General Research Institute goes red for heart month

    New Research Uncovers Gender Differences for Risk of Developing Heart Disease

    By mghresearch | 0 comment

    New research from Massachusetts General Hospital finds that having a certain type of body fat known as ectopic fat in the midsection may put women at a greater risk for developing heart disease and other cardiovascular health issues in comparison to men.

Leave a Comment

Cancel reply

Your email address will not be published. Required fields are marked *

Categories

Social

Tags

adolescents aging allergies ALS artificial intelligence brain health cancer treatments child health cholera clinical research clinical trials community health coronavirus dementia diagnostic tools diversity exercise Harvard health disparities heart attacks heart disease heart failure heart month hypertension image contest innovation internships kidney disease machine learning martinos center memory mental health microbiome Munn Center for Nursing Research nursing PET imaging postdocs public health Ragon Institute rare diseases researchers science writing sleep women's health women in medicine

Copyright 2020
Mass General Research Institute
All Rights Reserved

SUBSCRIBE TO BENCH PRESS


Contact

Mass General Research Institute
125 Nashua St.
Boston, MA 02114
617-724-0200
researchinstitute@mgh.harvard.edu
M-F: 9:00 am - 5:00 pm
  • Home
  • About
  • Research
    • Brain
    • Cancer
    • Heart
  • Communicating Science
  • Events
  • Home
  • About
  • Research
    • Brain
    • Cancer
    • Heart
    • More…
  • Communicating Science
  • Events
Bench Press